CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale General Counsel sold 4,730 shares at $9.76 ($46,155)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 484,496 shares at $10.32 ($4,999,999)
- 4 Open-market buy Director bought 484,496 shares at $10.32 ($4,999,999)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 484,496 shares at $10.32 ($4,999,999)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Open-market sale General Counsel sold 4,730 shares at an average $10.91 ($51,598)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 22 · 423 filings